24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

24/7 MN (NASDAQ: SLNO) SOLENO THERAPEUDICS INC. shares are on the move this morning as they announced further communications with the FDA concerning a randomized withdrawal period.

The stock is up more than 45% as of this post and is trading at .27 on more than 5600 trades and 6.8 million in volume as of this post

Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome

RelatedNews

Aridis Receives FDA Feedback on Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

Remark AI Awarded $6 million Rio De Janeiro police contract

Adamas One Acquires Minority Equity Stake in NexGenAI Solutions Group

LL Flooring Receives Unsolicited Buyout Offer

Marker Therapeutics Reports Positive MT-601 Pre-Clinical Data

Want more news like this? Check out our homepage!

Recent News

Aridis Receives FDA Feedback on Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

Remark AI Awarded $6 million Rio De Janeiro police contract

Adamas One Acquires Minority Equity Stake in NexGenAI Solutions Group

LL Flooring Receives Unsolicited Buyout Offer

Marker Therapeutics Reports Positive MT-601 Pre-Clinical Data

Follow Us

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Search by keyword

Add New Playlist